Evolus Financials

EOLS Stock  USD 14.00  0.15  1.08%   
Based on the key indicators related to Evolus' liquidity, profitability, solvency, and operating efficiency, Evolus Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Evolus' Other Stockholder Equity is comparatively stable compared to the past year. Short and Long Term Debt is likely to gain to about 112.9 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 21.2 M in 2024. Key indicators impacting Evolus' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.922.328
Significantly Up
Slightly volatile
The financial analysis of Evolus is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Evolus includes many different criteria found on its balance sheet. For example, investors should never minimize Evolus' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Evolus' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Evolus.

Net Income

(64.77 Million)

With this module, you can analyze Evolus financials for your investing period. You should be able to track the changes in Evolus individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Evolus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Evolus' financial statements are interrelated, with each one affecting the others. For example, an increase in Evolus' assets may result in an increase in income on the income statement.
Evaluating Evolus' financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Evolus' profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Evolus' relative financial performance

Chance Of Distress

Less than 39

 
100  
 
Zero
Below Average
Evolus Inc has less than 39 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Evolus stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Evolus' odds of distress score SHOULD NOT be confused with the real chance of Evolus Inc filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Evolus is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Evolus' liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Evolus' official financial statements usually reflect Evolus' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Evolus Inc. For example, before you start analyzing numbers published by Evolus accountants, it's critical to develop an understanding of what Evolus' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Evolus' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolus' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Evolus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evolus Inc. Please utilize our Beneish M Score to check the likelihood of Evolus' management manipulating its earnings.

Evolus Company Summary

Evolus competes with Agilent Technologies, Mustang Bio, Moleculin Biotech, Seres Therapeutics, and Madrigal Pharmaceuticals. Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Evolus operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 174 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001570562
ISINUS30052C1071
CUSIP30052C107
RegionNorth America
LocationCalifornia; U.S.A
Business Address520 Newport Center
SectorPharmaceuticals
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.evolus.com
Phone(949) 284 4555
CurrencyUSD - US Dollar
You should never invest in Evolus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evolus Stock, because this is throwing your money away. Analyzing the key information contained in Evolus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Evolus Key Financial Ratios

Generally speaking, Evolus' financial ratios allow both analysts and investors to convert raw data from Evolus' financial statements into concise, actionable information that can be used to evaluate the performance of Evolus over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Evolus Inc reports annually and quarterly.

Evolus Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets240.4M209.1M257.5M178.0M189.0M190.3M
Other Current Liab17.4M72.9M42.4M2.4M31.6M21.2M
Other Liab59.1M58.1M44.5M39.9M45.9M46.9M
Net Tangible Assets(1.4M)(149.5M)10.0M(51.3M)(59.0M)(62.0M)
Net Debt(13.3M)35.8M(71.5M)19.3M63.7M66.9M
Retained Earnings(213.1M)(376.1M)(422.9M)(497.3M)(559.0M)(531.0M)
Accounts Payable5.8M9.6M6.1M33.7M4.3M7.9M
Cash109.9M102.6M146.3M53.9M62.8M70.0M
Other Current Assets5.3M7.0M11.0M5.6M8.1M5.2M
Total Liab161.0M282.0M175.6M159.5M209.7M178.1M
Total Current Assets152.2M127.6M178.8M100.8M112.4M103.1M
Intangible Assets59.6M55.3M50.6M48.6M47.1M43.2M
Other Assets2.4M3.7M32.5M2.8M1.00.95
Net Invested Capital170.9M61M153.1M90.4M99.7M92.8M
Net Working Capital127.8M(52.6M)121.1M54.3M64.1M41.5M
Long Term Debt91.5M40.5M71.2M71.9M120.4M75.6M

Evolus Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Evolus' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense8.0M10.5M1.4M9.1M13.8M14.5M
Total Revenue34.9M56.5M99.7M148.6M202.1M212.2M
Gross Profit26.9M38.2M56.1M92.7M135.4M142.2M
Operating Income(94.8M)(68.7M)(63.6M)(57.6M)(36.1M)(37.9M)
Ebit(94.8M)(68.7M)(63.6M)(57.6M)(36.1M)(37.9M)
Research Development4.0M1.7M2.1M4.7M6.6M5.8M
Ebitda(93.0M)(59.0M)(64.3M)(59.5M)(30.2M)(31.8M)
Cost Of Revenue8.0M18.3M43.5M55.9M66.7M70.0M
Income Before Tax(105.1M)(162.9M)(46.8M)(74.3M)(61.5M)(64.6M)
Net Income(90.0M)(163.0M)(46.8M)(74.4M)(61.7M)(64.8M)
Income Tax Expense(15.0M)77K42K95K176K184.8K
Tax Provision(15.0M)77K42K95K176K184.8K
Net Interest Income(6.1M)(9.9M)(1.4M)(9.0M)(13.0M)(12.3M)
Interest Income1.8M635K1K119K860K487.6K

Evolus Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Evolus Inc. It measures of how well Evolus is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Evolus brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Evolus had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Evolus has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change In Cash16.7M(7.3M)43.7M(11.7M)8.9M12.7M
Net Borrowings70.7M39.5M(27.6M)(500K)(450K)(427.5K)
Free Cash Flow(98.0M)(61.0M)(34.4M)(11.7M)(35.6M)(37.4M)
Depreciation5.0M7.7M6.3M4.5M5.9M3.7M
Capital Expenditures4.6M3.1M970K2.9M1.6M1.6M
Net Income(90.0M)(163.0M)(46.8M)(74.4M)(61.7M)(64.8M)
Change To Netincome(990K)59.2M17.4M18.2M20.9M14.8M
Other Non Cash Items18.0M51.3M9.1M84.6M11.2M10.7M
End Period Cash Flow109.9M102.6M146.3M53.9M62.8M89.4M

Evolus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Evolus's current stock value. Our valuation model uses many indicators to compare Evolus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolus competition to find correlations between indicators driving Evolus's intrinsic value. More Info.
Evolus Inc is rated below average in retained earnings category among related companies. It is rated below average in price to earnings to growth category among related companies . At this time, Evolus' Retained Earnings are comparatively stable compared to the past year.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Evolus by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evolus' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolus' earnings, one of the primary drivers of an investment's value.

Evolus Inc Systematic Risk

Evolus' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evolus volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Evolus Inc correlated with the market. If Beta is less than 0 Evolus generally moves in the opposite direction as compared to the market. If Evolus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evolus Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evolus is generally in the same direction as the market. If Beta > 1 Evolus moves generally in the same direction as, but more than the movement of the benchmark.

About Evolus Financials

What exactly are Evolus Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Evolus' income statement, its balance sheet, and the statement of cash flows. Potential Evolus investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Evolus investors may use each financial statement separately, they are all related. The changes in Evolus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Evolus Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Evolus is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Evolus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Evolus' financials are consistent with your investment objective using the following steps:
  • Review Evolus' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Evolus' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Evolus' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Evolus' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in Evolus Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evolus' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Evolus growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.54

At this time, Evolus' Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Evolus March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Evolus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evolus Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evolus Inc based on widely used predictive technical indicators. In general, we focus on analyzing Evolus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evolus's daily price indicators and compare them against related drivers.
When determining whether Evolus Inc is a strong investment it is important to analyze Evolus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Evolus' future performance. For an informed investment choice regarding Evolus Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Evolus Stock analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Evolus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolus. If investors know Evolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.08)
Revenue Per Share
3.55
Quarterly Revenue Growth
0.398
Return On Assets
(0.12)
Return On Equity
(12.79)
The market value of Evolus Inc is measured differently than its book value, which is the value of Evolus that is recorded on the company's balance sheet. Investors also form their own opinion of Evolus' value that differs from its market value or its book value, called intrinsic value, which is Evolus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolus' market value can be influenced by many factors that don't directly affect Evolus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.